Literature DB >> 22870115

Histopathologic subtype-specific genomic profiles of renal cell carcinomas identified by high-resolution whole-genome single nucleotide polymorphism array analysis.

Akira Yokomizo1, Ken Yamamoto, Kenji Furuno, Masaki Shiota, Katsunori Tatsugami, Kentaro Kuroiwa, Seiji Naito.   

Abstract

To elucidate the novel and common genetic changes in histopathologic subtype-specific profiles of renal cell carcinomas (RCCs), a newly developed high-resolution whole-genome array analysis was applied. Human CNV370-Duo DNA Analysis BeadChip (genotype 370K) was used in a panel of 22 primary clear cell RCCs (ccRCCs), seven papillary RCCs (PRCCs) (six type II and one type I) and eight chromophobe RCCs (ChRCCs). In ccRCC, a chromosome 3p loss was identified in 95% of the carcinomas, suggesting that 3p loss is the first stage in ccRCC carcinogenesis. Other frequent changes included losses of 1p (23%), 3q (46%) and 8p (32%), and gains of 5q (32%), 7p (27%), 7q (27%) and 1q (23%). The most frequent chromosomal losses in PRCC (43%) were noted in 3p and 3q, followed by 29% of losses of 1p, 1q, 11q, 18q, 22p and 22q, and gains of 20q (57%), 20p (43%), 8q (43%) and 12q (43%). Loss of the entire chromosomes 1, 2, 6, 8, 10, 13 or 17 was noted in patients with ChRCC. A high-density single nucleotide polymorphism array analysis confirmed that partial chromosomal changes rarely occur in ChRCC. Additionally, 32 microdeletions and 10 microamplifications of less than 1 Mb were detected, which may represent potential candidate tumor suppressor genes and oncogenes, respectively.

Entities:  

Year:  2010        PMID: 22870115      PMCID: PMC3412451          DOI: 10.3892/ol.2010.187

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  16 in total

1.  Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization.

Authors:  M R Speicher; B Schoell; S du Manoir; E Schröck; T Ried; T Cremer; S Störkel; A Kovacs; G Kovacs
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

2.  Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.

Authors:  Dietmar Pfeifer; Milena Pantic; Ilona Skatulla; Justyna Rawluk; Clemens Kreutz; Uwe M Martens; Paul Fisch; Jens Timmer; Hendrik Veelken
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

Review 3.  Molecular targeting therapy for renal cell carcinoma.

Authors:  Masatoshi Eto; Seiji Naito
Journal:  Int J Clin Oncol       Date:  2006-06       Impact factor: 3.402

4.  Overexpression of the wild type p73 gene in human bladder cancer.

Authors:  A Yokomizo; M Mai; D J Tindall; L Cheng; D G Bostwick; S Naito; D I Smith; W Liu
Journal:  Oncogene       Date:  1999-02-25       Impact factor: 9.867

5.  Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.

Authors:  S C Clifford; A H Prowse; N A Affara; C H Buys; E R Maher
Journal:  Genes Chromosomes Cancer       Date:  1998-07       Impact factor: 5.006

6.  Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

Authors:  Toni K Choueiri; Anne Plantade; Paul Elson; Sylvie Negrier; Alain Ravaud; Stephane Oudard; Ming Zhou; Brian I Rini; Ronald M Bukowski; Bernard Escudier
Journal:  J Clin Oncol       Date:  2008-01-01       Impact factor: 44.544

7.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

8.  High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.

Authors:  T Yoshimoto; K Matsuura; S Karnan; H Tagawa; C Nakada; M Tanigawa; Y Tsukamoto; T Uchida; K Kashima; S Akizuki; I Takeuchi; F Sato; H Mimata; M Seto; M Moriyama
Journal:  J Pathol       Date:  2007-12       Impact factor: 7.996

9.  Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.

Authors:  C A Thrash-Bingham; H Salazar; J J Freed; R E Greenberg; K D Tartof
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

Review 10.  Gene array studies in renal neoplasia.

Authors:  John P T Higgins
Journal:  ScientificWorldJournal       Date:  2006-04-26
View more
  3 in total

1.  Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.

Authors:  Nicole M White-Al Habeeb; Ashley Di Meo; Andreas Scorilas; Fabio Rotondo; Olena Masui; Annetta Seivwright; Manal Gabril; Andrew H A Girgis; Michael A Jewett; George M Yousef
Journal:  Clin Exp Metastasis       Date:  2015-06-03       Impact factor: 5.150

Review 2.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

3.  Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.

Authors:  Maris Sperga; Petr Martinek; Tomas Vanecek; Petr Grossmann; Kevin Bauleth; Delia Perez-Montiel; Isabel Alvarado-Cabrero; Kristine Nevidovska; Vilnis Lietuvietis; Milan Hora; Michal Michal; Fredrik Petersson; Naoto Kuroda; Saul Suster; Jindrich Branzovsky; Ondrej Hes
Journal:  Virchows Arch       Date:  2013-08-03       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.